OWCP Ready Soon!I see two possible scenarios. One is it goes to .01 from here. If this happens there will be a slight price correction and then a jump. The other is that it goes to .0080 then up. Either option seems good to me. Good luck!
OWCP trade ideas
OWCP Ready to go longThe chart for OWCP looks ready to resume the upward trend. Look for continued higher lows.
OWCP- Watch for breakout above $0.60The 2018 Marijuana rush is here! OWCP should break out of its trading channels before the end of January 2018.
OWCP- watch for breakout above $0.60Looking for a breakout above $0.60, then up to $1 from there. OWCP is currently trading within the purple channel and against the curved line as support. It should break out above the channel before the end of January 2018. Lots of things happening with this company. 2018 Marijuana Rush is here.
OWCP under accumulationThe stock is in a short term consolidation stage. It bottomed at the end of September-17 and has been trending up in steps and has demonstrated resilience. In Q1-2018 the company is expected to announce results related to its CanaPsor014 which can propel the stock to the $2 - $3 range.
Psoriasis (Skin Disease)
• Preclinical “Dead Sea Study” showed up to 70% decline
of inflammatory skin disease markers and decline in
proliferation of Keratocytes
• Phase I safety study will be completed at Sheba Hospital,
Tel Hashomer in Q1/2018 – 26 patients
OWCP ready for the next leg upOTC:OWCP
Text book type chart self explanatory. After a log-term filling of gap it's making a gradual move to a probable FMV channel.
OWCP DAILY REVIEW Israeli-based research company engaged in the development of cannabinoid-based therapies; I am hoping its at its bottom and nowhere to go but up...
$OWCP Bullish Pennant Formation with Upcoming MJ Catalysts News ANNUAL REPORT CLARIFICATION FOR SHAREHOLDERS:
1)
Page 5: Don't get confused by the OWCP already done Psoriasis study (where efficacy results are imminent) and next deeper and extended studies planned from April: "On February 1, 2017, following the very encouraging results that have been achieved at the mid-point of the Study, the Company determined to extend the size and scope of the Study for the purpose, among other things, of checking the biological markers that have been generated to date with respect to the treatment of psoriasis (proliferation/ inhibition and several interleukins). Despite extending its size and scope of the Study, the Registrant expects to compete the Study during the 2 nd or 3 rd quarters of 2017."
The study already done is confirmed in page 36:
"We have been conducting a study on the efficacy of the cannabinoid-based topical cream for the treatment of skin conditions generally and psoriasis specifically, which commenced in November, 2016 "
While the extended study to start in April 2017 according to previous 8K is the safety phase and identification of biological markers useful to identify potential other application of the cream (Skin Cancer imo):
"We started safety phase at the hospital by this month, April 2017, and already planning a unique multi-center efficacy study. This is the natural development of the next generation of safe and tested cannabinoids treatments"
2)
Page 5-6: Multiple Myeloma Amazing News for Shareholders is here:
"Dr. Leiba led our in vitro studies on the effect of a formulation comprised of Cannabidiol (CBD) and tetrahydrocannabinol (THC) on multiple myeloma cells studied outside their normal biological context. The results indicated a 100% mortality rate of myeloma cells in 80% of the cultured cells within a 24 to 48-hour period, and highlight the potential abilities of cannabis oil extract to fight multiple myeloma cancer cells. We believe that the results of this study indicate a potential to develop a more effective treatment for multiple myeloma than standard therapies."
"Expect to submit a clinical trial protocol to the Israeli Institutional Review Board and received its approval to commence a clinical study"
"Intend to commence a clinical study in the third quarter of 2017"
3)
Notes on competition page 7: For Psoriasis they aim to attack Big Pharma market and they are well aware of current products and thier limitation:
"The current common treatments for psoriasis include topical and systemic drugs, steroids, immunosuppressive drugs such as Cyclosporine A (by Novartis), methotrexate or MTX and biological drugs such as Enbrel (by Amgen), Amevive (by Biogen but whose patent expired in 2013) and Ustakinumabn (by Janssen Immunology)." This is excelent Marketing strategic approach;
4)
Page 8: Provisional Patents are listed in report, can be downloaded through reference number and are real! They are extremely well written in a professional way and full of interesting claims: when needed (close to deadline) they will pay the service fees and transform them in Official US Permanent Patent; Why to do it before if the provisional is free of charge? Smart approach;
5)
Page 12: CERTIFICATION and FDA approval all diligently work has been done according to standard: "
Israel’s Ministry of Health, which regulates medical testing, has adopted protocols that correspond, generally, to those of the FDA and the EMA, making it comparatively straightforward for studies conducted in Israel to satisfy FDA and the European Medicines Agency requirements, thereby enabling medical technologies subjected to clinical trials in Israel to reach U.S. and EU commercial markets in an expedited fashion. Many members of Israel’s medical community have earned international prestige in their chosen fields of expertise and routinely collaborate, teach and lecture at leading medical centers throughout the world. Israel also has free trade agreements with the United States
$OWCP Why I'm Extremely Long on This $5.00 by EOMI was in on the initial run .0030 - .10 bought and sold from .10 - $3.00 bought and sold (both times sold too early) and now .50 - $5.00 Here's why:
PROVISIONAL PATENTS TAKE ABOUT 8-12 MONTHS TO GET TURNED INTO APPROVED PATENTS.
Here's the list of $OWCP Patents:
1) patentscope.wipo.int
2) patentscope.wipo.int
3) patentscope.wipo.int
4) patentscope.wipo.int
5) patentscope.wipo.int
6) patentscope.wipo.int
7) patentscope.wipo.int
Also the Patent Document: www.docdroid.net
FROM THE 8K ON APRIL 4TH: OWC Pharmaceutical Research Corp. ("OWC") is reporting the issuance on April 5, 2017 of the attached press release, announcing that as a result of the promising conclusions reported in its Form 8-K filed on March 20, 2017, the Company has received expressions of scientific and medical interest, world-wide, for its cannabinoid-based topical cream for treating psoriasis. OWCP has expanded the size and scope of its clinical studies and, as previously announced, anticipates that subject to pending regulatory approvals from applicable jurisdictions, the topical cream should be available for use by those who suffer from psoriasis in the near term.
ALSO LETS NOT FORGET 4/20
In addition we have many news outlets covering MJ which is bringing it back into the light.
CANADA LEGALIZING IT NATIONWIDE.
Too many catalysts to cover.
Once we break key resistance tomorrow we could see $2.00 by EOD
SHORTYou should immediately short this stock, this is as high as it can go. It will go down. This is your chance to profit from it
OWCP is not going to the moon.While many fans of marijuana stocks are pointing towards an upward move, i am sure that this stock has reached it's peak for a long time now. The chart shows a lot of stagnation and resistance near 0.70 and the stock could dip lower anytime now.
Many factors point towards a red flag:
1) This company is based overseas, and conducts research overseas, meaning there are very few ways to monitor their progress when it comes to their claims.
2) This is still a pennystock, while some might be tempted to take risks, the slightest mistake by the company will cause investors to lose all their money, rapidly.
3) If the pharmaceutical research fails, the owners could dump their shares knowing they cannot profit further from this venture, causing investors to lose their money.
4) The only product they got going for them is a skin cream, and this has very little impact of the market as it is.
I see people pumping thousands into this stock hoping for an easy pay day, don't do it. Wait until it dips and take the risk on a smaller scale, if it goes up, average up and rack in the money. Is this a pump and dump ? Judging from the company's audited statements, probably not, however they are walking on thin ice here, so don't jump into the hype.
OWCP GOING FOR A DEEPER CORRECTION?OWCP is spiking after the release of his annual letter to the Company's shareholders, presenting their goals and objective for the upcoming 2017. Now there is a strong rejection, i'm expecting a deeper correction.
Good long into 2017 Check out OWCP :)check out the security OWCP looking to match GWPH and recently featured on Blooms-berg to the beginning of sales of there psoriasis cream and mmj tablets to be distributed in the U.K and the U.S on new states as well.
